Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.
Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.
<iframe src="https://statesidedaily.com/embed/cluster/1cecb8c30fbc50a216791401de08b2c8149187bb" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds"></iframe>
